002817.SZ · 黄山胶囊
China A-shares · RS rating 70 · As of 2026-10-14
| Price | 6.58 CNY |
|---|---|
| 1-day change | -2.7% |
| RS rating (overall / 1M / 3M / 12M) | 70 / 65 / 76 / 55 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 22 / 25 / 11 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -1.1% |
| Distance from 52-week high | +22.9% |
| Market cap (USD) | $305.5M |